| PBMC | peripheral blood mononuclear cells |
| HVEM | herpes virus entry mediator |
| BTLA | B and T lymphocyte attenuator |
| TILs | tumor-infiltrating leukocytes |
| NSG | NOD.SCID.γc-null |
| ICI | immune checkpoint inhibitors |
| RNP | ribonucleoproteins |
| DEG | differentially expressed genes |
| GVHD | graft vs. host disease |
| IPA | ingenuity pathway analysis |
| GSEA | gene set enrichment analysis |
| FDR | false discovery rate |
| FWER | family-wise error rate |
| PDX | patient-derived xenografts |
| PCa | prostate cancer |
| TCGA | The Cancer Genome Atlas |
| PRAD | prostate adenocarcinomas |
| PFI | progression-free interval |